Hos patienter med lokalt avanceret sygdom er fordelen mindre efter operation og når strålebehandlingen kan forventes at være kurativ.
Benefit is generally a function of risk progression and in patients with locally advanced disease; benefit is reduced after surgery or in cases where radiotherapy is likely to be curative.